Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated …
Introduction Tyrosine kinase inhibitors (TKIs) have significantly improved the progression-
free survival (PFS) of metastatic non-small cell lung cancer (NSCLC) with oncogene …
free survival (PFS) of metastatic non-small cell lung cancer (NSCLC) with oncogene …
[PDF][PDF] Prognostication in malignant pleural effusion: One size does not fit all
ASL Dipper, NA Maskell - Respirology, 2020 - research-information.bris.ac.uk
Physicians are poor at predicting survival in patients with malignant pleural effusion (MPE).
This is exemplified by the TIME 2 trial 1 where, despite criteria precluding trial entry with an …
This is exemplified by the TIME 2 trial 1 where, despite criteria precluding trial entry with an …
Lung cancer cells induce senescence and apoptosis of pleural mesothelial cells via transforming growth factor-beta1
ZF Miao, WY Li, ZN Wang, TT Zhao, YY Xu, YX Song… - Tumor Biology, 2015 - Springer
Pleural dissemination is commonly associated with metastatic advanced lung cancer. The
injury of pleural mesothelial cells (PMCs) by soluble factors, such as transforming growth …
injury of pleural mesothelial cells (PMCs) by soluble factors, such as transforming growth …
Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world
P Pan, F Wu, Z Xu, X Ji, Q Qi, X Huang, R Zhao… - Thoracic …, 2021 - Wiley Online Library
Background The aim of the study was to assess the efficacy and side‐effects of intrapleural
treatment in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusions …
treatment in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusions …
VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation
VI Peppa, ZV Arsenopoulou, SG Zarogiannis… - Cytokine, 2014 - Elsevier
Vascular endothelial growth factor (VEGF), a cytokine that increases vascular permeability to
water and proteins and induces angiogenesis, has been implicated in the development of …
water and proteins and induces angiogenesis, has been implicated in the development of …
[HTML][HTML] 胸腔热灌注化疗治疗肺癌恶性胸腔积液临床疗效的Meta 分析
李俏苒， 戎彪学 - Advances in Clinical Medicine, 2023 - hanspub.org
目的: 探讨胸腔热灌注化疗治疗肺癌恶性胸腔积液的临床疗效及安全性. 方法:
计算机检索PubMed, 中国期刊全文数据库(CNKI), 万方数据库, 维普数据库(VIP) …
计算机检索PubMed, 中国期刊全文数据库(CNKI), 万方数据库, 维普数据库(VIP) …
[HTML][HTML] Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success
S Alsayed, S Marzouk, S Abelhalim, E Mousa - Egyptian Journal of Chest …, 2015 - Elsevier
Abstract Background 42–77% of exudative pleural effusions are due to malignant diseases
(Marel et al., 1993)[1]. This study aimed to evaluate the value of biochemical parameters of …
(Marel et al., 1993)[1]. This study aimed to evaluate the value of biochemical parameters of …
[HTML][HTML] Good response of malignant pleural effusion from carcinoma of unknown primary site to the anti-tuberculosis therapy: a case report
Q Gu, C Hu, J Qu - … journal of clinical and experimental pathology, 2013 - ncbi.nlm.nih.gov
Malignant pleural effusion in patients with cancers or malignant pleural mesothelioma may
often appear at the late stage of disease and significantly affect the patients' life quality and …
often appear at the late stage of disease and significantly affect the patients' life quality and …